These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 25896690)

  • 1. Origins of Yersinia pestis sensitivity to the arylomycin antibiotics and the inhibition of type I signal peptidase.
    Steed DB; Liu J; Wasbrough E; Miller L; Halasohoris S; Miller J; Somerville B; Hershfield JR; Romesberg FE
    Antimicrob Agents Chemother; 2015 Jul; 59(7):3887-98. PubMed ID: 25896690
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Type I signal peptidase and protein secretion in Staphylococcus aureus.
    Schallenberger MA; Niessen S; Shao C; Fowler BJ; Romesberg FE
    J Bacteriol; 2012 May; 194(10):2677-86. PubMed ID: 22447899
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanism of action of the arylomycin antibiotics and effects of signal peptidase I inhibition.
    Smith PA; Romesberg FE
    Antimicrob Agents Chemother; 2012 Oct; 56(10):5054-60. PubMed ID: 22802255
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Curative Treatment of Severe Gram-Negative Bacterial Infections by a New Class of Antibiotics Targeting LpxC.
    Lemaître N; Liang X; Najeeb J; Lee CJ; Titecat M; Leteurtre E; Simonet M; Toone EJ; Zhou P; Sebbane F
    mBio; 2017 Jul; 8(4):. PubMed ID: 28743813
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasmid-mediated doxycycline resistance in a Yersinia pestis strain isolated from a rat.
    Cabanel N; Bouchier C; Rajerison M; Carniel E
    Int J Antimicrob Agents; 2018 Feb; 51(2):249-254. PubMed ID: 29030266
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of Protein Secretion in
    Walsh SI; Peters DS; Smith PA; Craney A; Dix MM; Cravatt BF; Romesberg FE
    Antimicrob Agents Chemother; 2019 Feb; 63(2):. PubMed ID: 30420476
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Broad-spectrum antibiotic activity of the arylomycin natural products is masked by natural target mutations.
    Smith PA; Roberts TC; Romesberg FE
    Chem Biol; 2010 Nov; 17(11):1223-31. PubMed ID: 21095572
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lack of O-antigen is essential for plasminogen activation by Yersinia pestis and Salmonella enterica.
    Kukkonen M; Suomalainen M; Kyllönen P; Lähteenmäki K; Lång H; Virkola R; Helander IM; Holst O; Korhonen TK
    Mol Microbiol; 2004 Jan; 51(1):215-25. PubMed ID: 14651623
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The inhibition of type I bacterial signal peptidase: Biological consequences and therapeutic potential.
    Craney A; Romesberg FE
    Bioorg Med Chem Lett; 2015 Nov; 25(21):4761-4766. PubMed ID: 26276537
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intraspecies and temperature-dependent variations in susceptibility of Yersinia pestis to the bactericidal action of serum and to polymyxin B.
    Anisimov AP; Dentovskaya SV; Titareva GM; Bakhteeva IV; Shaikhutdinova RZ; Balakhonov SV; Lindner B; Kocharova NA; Senchenkova SN; Holst O; Pier GB; Knirel YA
    Infect Immun; 2005 Nov; 73(11):7324-31. PubMed ID: 16239530
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A multicopy suppressor screening approach as a means to identify antibiotic resistance determinant candidates in Yersinia pestis.
    Stirrett KL; Ferreras JA; Rossi SM; Moy RL; Fonseca FV; Quadri LE
    BMC Microbiol; 2008 Jul; 8():122. PubMed ID: 18644132
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel Disk Diffusion Assay on Magnesium Oxalate Agar To Evaluate the Susceptibility of Yersinia pestis to Type III Secretion System Inhibitors.
    Prashar S; Portales Guemes M; Shivbaran P; Jimenez Alvarez E; Soha C; Nacer S; McDonough M; Plano GV; Torruellas Garcia J
    Microbiol Spectr; 2021 Sep; 9(1):e0000521. PubMed ID: 34132578
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of late acyltransferase genes of Yersinia pestis and their role in temperature-dependent lipid A variation.
    Rebeil R; Ernst RK; Jarrett CO; Adams KN; Miller SI; Hinnebusch BJ
    J Bacteriol; 2006 Feb; 188(4):1381-8. PubMed ID: 16452420
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel mechanism of streptomycin resistance in Yersinia pestis: Mutation in the rpsL gene.
    Dai R; He J; Zha X; Wang Y; Zhang X; Gao H; Yang X; Li J; Xin Y; Wang Y; Li S; Jin J; Zhang Q; Bai J; Peng Y; Wu H; Zhang Q; Wei B; Xu J; Li W
    PLoS Negl Trop Dis; 2021 Apr; 15(4):e0009324. PubMed ID: 33886558
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A putative cro-like repressor contributes to arylomycin resistance in Staphylococcus aureus.
    Craney A; Romesberg FE
    Antimicrob Agents Chemother; 2015; 59(6):3066-74. PubMed ID: 25753642
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro efficacy of antibiotics commonly used to treat human plague against intracellular Yersinia pestis.
    Wendte JM; Ponnusamy D; Reiber D; Blair JL; Clinkenbeard KD
    Antimicrob Agents Chemother; 2011 Aug; 55(8):3752-7. PubMed ID: 21628541
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microarray expression profiling of Yersinia pestis in response to chloramphenicol.
    Qiu J; Zhou D; Qin L; Han Y; Wang X; DU Z; Song Y; Yang R
    FEMS Microbiol Lett; 2006 Oct; 263(1):26-31. PubMed ID: 16958847
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Not just an antibiotic target: Exploring the role of type I signal peptidase in bacterial virulence.
    Walsh SI; Craney A; Romesberg FE
    Bioorg Med Chem; 2016 Dec; 24(24):6370-6378. PubMed ID: 27769673
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Crystallographic analysis of bacterial signal peptidase in ternary complex with arylomycin A2 and a beta-sultam inhibitor.
    Luo C; Roussel P; Dreier J; Page MG; Paetzel M
    Biochemistry; 2009 Sep; 48(38):8976-84. PubMed ID: 19655811
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of Gentamicin Concentration and Exposure Time on Intracellular
    VanCleave TT; Pulsifer AR; Connor MG; Warawa JM; Lawrenz MB
    Front Cell Infect Microbiol; 2017; 7():505. PubMed ID: 29312891
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.